Liver disease in the HIV-infected individual
- PMID: 20851211
- PMCID: PMC2997131
- DOI: 10.1016/j.cgh.2010.08.024
Liver disease in the HIV-infected individual
Abstract
Since the advent of effective antiretroviral therapy (ART) for human immunodeficiency virus-1 (HIV), there has been a substantial decrease in deaths related to acquired immunodeficiency syndrome (AIDS). However, in the ART era, liver disease is now the most common non-AIDS-related cause of death among HIV-infected patients, accounting for 14%-18% of all deaths in this population and almost half of deaths among hospitalized HIV-infected patients. Just as the burden of non-AIDS morbidity and mortality has changed in the ART era, the types of liver disease the clinician is likely to encounter among these patients have changed as well. This review will discuss the causes of liver disease in the HIV-infected population in the ART era, including chronic hepatitis C virus, chronic hepatitis B virus, medication-related hepatotoxicity, alcohol abuse, nonalcoholic fatty liver disease, and AIDS-related liver diseases.
Copyright © 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Prevalence and factors associated with liver test abnormalities among human immunodeficiency virus-infected persons.Clin Gastroenterol Hepatol. 2010 Feb;8(2):183-91. doi: 10.1016/j.cgh.2009.09.025. Epub 2009 Oct 2. Clin Gastroenterol Hepatol. 2010. PMID: 19800985 Free PMC article.
-
Antiretroviral Therapies for Human Immunodeficiency Virus and Liver Disease: Challenges and opportunities.Ann Hepatol. 2020 Mar-Apr;19(2):121-122. doi: 10.1016/j.aohep.2020.02.004. Ann Hepatol. 2020. PMID: 32138869
-
The burden of liver disease in human immunodeficiency virus-infected patients.Semin Liver Dis. 2012 May;32(2):103-13. doi: 10.1055/s-0032-1316473. Epub 2012 Jul 3. Semin Liver Dis. 2012. PMID: 22760649 Review.
-
Increasing burden of liver disease in patients with HIV infection.Lancet. 2011 Apr 2;377(9772):1198-209. doi: 10.1016/S0140-6736(10)62001-6. Lancet. 2011. PMID: 21459211 Review.
-
Predictors of severe hepatotoxicity among retroviral infected adults on HAART regimen in Ilubabor Zone, Southwest Ethiopia.Sci Rep. 2024 Apr 11;14(1):8473. doi: 10.1038/s41598-024-57900-7. Sci Rep. 2024. PMID: 38605149 Free PMC article.
Cited by
-
Substance Use, Highly Active Antiretroviral Therapy, and Liver Enzymes: Evidence From a Cross-Sectional Study of HIV-Infected Adult Patients Without Comorbidities on HAART in the University of Port Harcourt Teaching Hospital.Front Reprod Health. 2021 Jun 28;3:664080. doi: 10.3389/frph.2021.664080. eCollection 2021. Front Reprod Health. 2021. PMID: 36303994 Free PMC article.
-
Liver cancer mortality trends in South Africa: 1999-2015.BMC Cancer. 2018 Aug 7;18(1):798. doi: 10.1186/s12885-018-4695-9. BMC Cancer. 2018. PMID: 30086727 Free PMC article.
-
Prevalence and predictors of liver disease in HIV-infected children and adolescents.Sci Rep. 2017 Sep 26;7(1):12309. doi: 10.1038/s41598-017-11489-2. Sci Rep. 2017. PMID: 28951598 Free PMC article.
-
Alcohol-Induced Lysosomal Damage and Suppression of Lysosome Biogenesis Contribute to Hepatotoxicity in HIV-Exposed Liver Cells.Biomolecules. 2021 Oct 11;11(10):1497. doi: 10.3390/biom11101497. Biomolecules. 2021. PMID: 34680130 Free PMC article.
-
Differential regulation of cytotoxicity pathway discriminating between HIV, HCV mono- and co-infection identified by transcriptome profiling of PBMCs.Virol J. 2015 Jan 27;12:4. doi: 10.1186/s12985-014-0236-6. Virol J. 2015. PMID: 25623235 Free PMC article.
References
-
- Schneider MF, Gange SJ, Williams CM, et al. Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984-2004. AIDS. 2005;19(17):2009–2018. - PubMed
-
- Palella FJ, Jr., Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338(13):853–860. - PubMed
-
- Palella FJ, Jr., Baker RK, Moorman AC, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr. 2006;43(1):27–34. - PubMed
-
- Group TDCoAEoA-HIVdS Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D study. AIDS. 2010;24(10):1537–1548. - PubMed
-
- Bica I, McGovern B, Dhar R, et al. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis. 2001;32(3):492–497. - PubMed